Timing of Neural Tissue Transplants for Brain Injuries
Chronic Versus Acute Transplantation of Neural Tissues for TBI-Induced Cortical Injuries
This work explores the best time to replace damaged brain cells after a traumatic brain injury to help restore brain function.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11129839 on NIH RePORTER |
What this research studies
Traumatic brain injuries often cause lasting neurological and cognitive problems because parts of the brain's outer layer, the cerebral cortex, are damaged. Currently, there are no treatments to fully repair these injuries. This project looks at a promising approach called cell replacement, where new neural tissues are introduced to connect with the existing brain and help it work better. We are exploring whether transplanting these tissues soon after injury, or later, makes a difference in how well they integrate and improve brain function. The goal is to understand the optimal timing for these transplants to achieve the best possible recovery.
Who could benefit from this research
Good fit: This foundational work is for individuals with traumatic brain injuries who might benefit from future cell replacement therapies.
Not a fit: Patients without traumatic brain injuries or those whose injuries are not related to cortical damage may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that restore brain function and reduce disability for individuals who have experienced traumatic brain injuries.
How similar studies have performed: While cell replacement is a promising strategy, the optimal timing for transplantation after traumatic brain injury is an essential issue that has not been systematically examined.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Chen, Han-Chiao Isaac — University of Pennsylvania
- Study coordinator: Chen, Han-Chiao Isaac
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.